Clinical Trial Update: Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Angiomax (bivalirudin) versus heparin in acute coronary syndromes has completed. The study addressed unstable angina and myocardial infa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Unstable Angina

Drugs mentioned

• Angiomax (bivalirudin)
• Heparin (unfractionated heparin)

Snippet

Sponsor: The Medicines Company | Conditions: Unstable Angina, Myocardial Infarction | Phase 3 | Status: COMPLETED